rss
Postgrad Med J 2002;78:646-650 doi:10.1136/pmj.78.925.646
  • Review

Improving the utility of prostate specific antigen (PSA) in the diagnosis of prostate cancer: the use of PSA derivatives and novel markers

  1. S Jain,
  2. A G Bhojwani,
  3. J K Mellon
  1. Division of Urology, University of Leicester, Leicester General Hospital, Leicester, UK
  1. Correspondence to:
 Mr Sunjay Jain, Division of Urology, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4PW, UK; 
 sj34{at}le.ac.uk
  • Received 28 May 2002
  • Accepted 22 July 2002

Abstract

Prostate specific antigen (PSA) testing is now a routine part of the investigation of men with suspected prostate cancer. While a very useful test it still has its problems, in particular its lack of specificity means abnormal results are often caused by benign disease. This review describes the current problems with PSA testing in prostate cancer diagnosis and highlights potential ways in which these may be reduced.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.